Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
401k Retirement Calculator
Mortgage Calculator
Popular
Compound Interest Calculator
Dollar Cost Averaging
New
Student Loan Calculator
Auto Loan Calculator
Personal Finance
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
ATOS
Stock Latest News
Press Releases
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
5d ago
ATOS
Premium
The Fly
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
5d ago
ATOS
Premium
Press Releases
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
9d ago
ATOS
Premium
Press Releases
Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
10d ago
ATOS
Premium
The Fly
Atossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial
10d ago
ATOS
Premium
Company Announcements
Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance
17d ago
ATOS
Premium
Press Releases
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
18d ago
ATOS
Premium
Pre-Earnings
Is ATOS a Buy, Before Earnings?
25d ago
ATOS
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
28d ago
ATOS
BCEL
Premium
The Fly
Atossa Therapeutics provides five-year (Z)-endoxifen update
30d ago
ATOS
Premium
The Fly
Atossa Therapeutics provides five-year Z-Endoxifen treatment update
1M ago
ATOS
Premium
Press Releases
Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved “Expanded Access” Program for a U.S. Breast Cancer Patient
1M ago
ATOS
Premium
Press Releases
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
1M ago
ATOS
Premium
The Fly
Atossa Therapeutics regains compliance with Nasdaq minimum bid price rule
1M ago
ATOS
Premium
Company Announcements
Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance
1M ago
8K
ATOS
Premium
The Fly
Atossa Therapeutics appoints Tessa Cigler to board of directors
1M ago
ATOS
Premium
Press Releases
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
1M ago
ATOS
Premium
The Fly
Atossa Therapeutics announces first patient dosing of Z-endoxifen
2M ago
ATOS
Premium
The Fly
Atossa Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
ATOS
Premium
Press Releases
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
2M ago
ATOS
Premium
The Fly
Atossa announces full enrollment of Z-endoxifen arm of I-SPY 2 trial
2M ago
ATOS
Premium
Press Releases
Atossa Therapeutics Issues Letter to Shareholders
3M ago
ATOS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
